JnJ gets CDSCO Panel nod to study antipsychotic drug Paliperidone Palmitate Dr. Divya Colin29 Sep 2022 12:30 PM GMTNew Delhi: Pharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard...
Johnson and Johnson to split into 2 companies Medical Dialogues Team13 Nov 2021 11:31 AM GMTNew Delhi: US pharma giant Johnson and Johnson (JnJ) has recently announced that it is splitting into two companies, separating the division that...
Setback: Johnson and Johnson halts Covid vaccine trial over unexplained illness in participant Ruchika Sharma13 Oct 2020 7:32 AM GMTThe participant's illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company's clinical and...
JnJ vaccine raises neutralizing antibodies, prevents severe COVID-19 in hamsters Ruchika Sharma6 Sep 2020 5:15 AM GMTThe vaccine, co-developed by the Beth Israel Deaconess Medical Center and Johnson & Johnson (JnJ), uses a common cold virus, called adenovirus...
